The hypercoagulability of polycythemia vera.
Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
Fields
W
W
Brown University.
Freeman
N J
NJ
D000368:Aged; D001778:Blood Coagulation Disorders / Q000097:blood* / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D001815:Bloodletting; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011087:Polycythemia Vera / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D013927:Thrombosis / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000628:therapy